Gilead Sciences (GILD) News Today $106.54 +2.33 (+2.24%) As of 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period Gilead Sciences: Hold Rating Maintained Amid Near-Term Challenges and Limited Growth ProspectsApril 30 at 2:34 PM | tipranks.comCalifornia State Teachers Retirement System Cuts Stake in Gilead Sciences, Inc. (NASDAQ:GILD)California State Teachers Retirement System lowered its stake in shares of Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 3.2% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,984,447 shares of the biopharmaceuticApril 30 at 8:00 AM | marketbeat.comNorthern Trust Corp Acquires 2,458,954 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)Northern Trust Corp increased its stake in Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 19.7% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 14,915,095 shares of the biopharmaceutical company'sApril 30 at 7:52 AM | marketbeat.comThe Manufacturers Life Insurance Company Sells 33,693 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)The Manufacturers Life Insurance Company lowered its position in Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 0.5% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 6,308,718 shares of the biopharmaceutical company'April 30 at 7:49 AM | marketbeat.comGilead Sciences Q1 Earnings TranscriptApril 30 at 7:05 AM | marketbeat.comGilead Sciences, Inc. (NASDAQ:GILD) Shares Sold by Public Employees Retirement Association of ColoradoPublic Employees Retirement Association of Colorado lowered its holdings in Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 3.2% during the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 167,714 shares of the biopharmaceutical company's stock afApril 30 at 7:03 AM | marketbeat.comKovitz Investment Group Partners LLC Decreases Stock Position in Gilead Sciences, Inc. (NASDAQ:GILD)Kovitz Investment Group Partners LLC cut its holdings in Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 62.7% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 36,342 shares of the biopharmaceutical cApril 30 at 5:48 AM | marketbeat.comGilead Sciences to pay $202 million in US settlement over HIV drug kickbacksApril 29 at 3:11 PM | investing.comGilead Sciences reaches $202 million settlement with US over kickbacks to doctorsApril 29 at 1:51 PM | reuters.comGilead Sciences agrees to pay $202 million to settle claims of kickbacks to doctors for HIV drug prescriptionsApril 29 at 1:45 PM | cnbc.comGilder Gagnon Howe & Co. LLC Purchases 17,437 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)Gilder Gagnon Howe & Co. LLC grew its position in Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 88.5% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 37,144 shares of the biopharmaceutical company's stock after aApril 29 at 6:15 AM | marketbeat.comFY2025 EPS Estimates for Gilead Sciences Lifted by AnalystApril 29 at 2:25 AM | americanbankingnews.comCantor Fitzgerald Predicts Gilead Sciences FY2025 EarningsGilead Sciences, Inc. (NASDAQ:GILD - Free Report) - Stock analysts at Cantor Fitzgerald upped their FY2025 earnings estimates for shares of Gilead Sciences in a research note issued to investors on Friday, April 25th. Cantor Fitzgerald analyst C. Gould now expects that the biopharmaceutical compaApril 29 at 2:23 AM | marketbeat.comSusquehanna Fundamental Investments LLC Buys Shares of 297,026 Gilead Sciences, Inc. (NASDAQ:GILD)Susquehanna Fundamental Investments LLC purchased a new position in shares of Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 297,026 shares of the biopharApril 28 at 6:37 AM | marketbeat.comGilead Sciences, Inc. (NASDAQ:GILD) Shares Bought by MGO One Seven LLCMGO One Seven LLC raised its position in Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 70.8% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 11,195 shares of the biopharmaceutical company's stock after acquiring an additional 4,639 shares during the perioApril 28 at 5:18 AM | marketbeat.comPrice T Rowe Associates Inc. MD Buys 198,528 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)Price T Rowe Associates Inc. MD increased its stake in Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 5.9% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 3,546,721 shares of the biopharmaceutical company's stock after purchasing an additioApril 28 at 5:08 AM | marketbeat.comGilead Sciences (NASDAQ:GILD) Given New $125.00 Price Target at OppenheimerApril 28 at 3:01 AM | americanbankingnews.comGilead Sciences (GILD) Adjusts EPS Outlook Despite Revenue StabilityApril 27 at 9:26 PM | gurufocus.comGilead Sciences: Dividend Investors Must Be CautiousApril 27 at 3:29 PM | seekingalpha.comGilead Sciences (NASDAQ:GILD) Given Hold Rating at Needham & Company LLCNeedham & Company LLC reaffirmed a "hold" rating on shares of Gilead Sciences in a research note on Friday.April 27 at 9:26 AM | marketbeat.comVoya Investment Management LLC Has $75.46 Million Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)Voya Investment Management LLC cut its stake in Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 5.9% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 816,893 shares of the biopharmaceutical company's stoApril 27 at 6:18 AM | marketbeat.comJefferies Keeps Their Buy Rating on Gilead Sciences (GILD)April 26, 2025 | markets.businessinsider.comGilead Sciences, Inc. (NASDAQ:GILD) Shares Sold by Banco Bilbao Vizcaya Argentaria S.A.Banco Bilbao Vizcaya Argentaria S.A. lessened its stake in Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 5.1% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 559,884 shares of the biopharmaceutical company'sApril 26, 2025 | marketbeat.comOneDigital Investment Advisors LLC Reduces Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)OneDigital Investment Advisors LLC reduced its stake in Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 15.2% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 27,473 shares ofApril 26, 2025 | marketbeat.comGilead Sciences, Inc. (GILD) Stock ForecastsApril 26, 2025 | finance.yahoo.comGilead Sciences, Inc. (GILD) Stock ForecastsApril 26, 2025 | finance.yahoo.comGilead Sciences Stock Falls as Slumping COVID-19, Cancer Drug Sales Hit RevenueApril 26, 2025 | msn.comGilead Sciences Stock Falls as Slumping COVID-19, Cancer Drug Sales Hit RevenueApril 26, 2025 | msn.comGilead Sciences’ Earnings Call: Growth Amid ChallengesApril 25, 2025 | tipranks.comGilead Sciences (GILD) Faces Target Price Cut Amid Revenue Shortfall | GILD Stock NewsApril 25, 2025 | gurufocus.comWhy Gilead Sciences Stock Slipped TodayApril 25, 2025 | fool.comGilead Sciences Q1 Earnings Review: HIV Division Masks UnderperformanceApril 25, 2025 | seekingalpha.comGilead Sciences Q1 Earnings Review: HIV Division Masks UnderperformanceApril 25, 2025 | seekingalpha.comGilead Sciences falls as Q1 revenue misses estimates on soft HIV, Trodelvy salesApril 25, 2025 | in.investing.comAnalysts Set Expectations for Gilead Sciences FY2025 EarningsApril 25, 2025 | americanbankingnews.comGilead options imply 3.7% move in share price post-earningsApril 25, 2025 | markets.businessinsider.comGilead down 3% at $102.98 after Q1 results, affirmed FY25 guidanceApril 25, 2025 | markets.businessinsider.comQ1 2025 Gilead Sciences Inc Earnings Call TranscriptApril 25, 2025 | gurufocus.comGilead posts profit, says HIV prevention drug on track for mid-JuneApril 24, 2025 | msn.comGilead Sciences (NASDAQ:GILD) Misses Q1 Revenue EstimatesApril 24, 2025 | msn.comGilead Sciences, Inc. (GILD) Q1 2025 Earnings Call TranscriptApril 24, 2025 | seekingalpha.comGilead Sciences Stock Slips After Mixed Q1 Results, Lowered FY25 EPS GuidanceApril 24, 2025 | benzinga.comGilead Sciences (GILD) Reports Mixed Q1 2025 Results Amid Sales ShiftsApril 24, 2025 | gurufocus.comGilead Sciences shares fall as Q1 revenue misses estimatesApril 24, 2025 | investing.comGilead Sciences 1Q EPS $1.04 >GILDApril 24, 2025 | marketwatch.comGilead Sciences, Inc. 2025 Q1 - Results - Earnings Call PresentationApril 24, 2025 | seekingalpha.comGilead reports quarterly profit, revenue flat as cancer sales slowApril 24, 2025 | reuters.comGilead Sciences Announces First Quarter 2025 Financial ResultsApril 24, 2025 | businesswire.comAdage Capital Partners GP L.L.C. Buys New Shares in Gilead Sciences, Inc. (NASDAQ:GILD)Adage Capital Partners GP L.L.C. purchased a new stake in shares of Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 1,714,130 shares of the biopharmaceutical cApril 24, 2025 | marketbeat.comSyon Capital LLC Purchases 3,678 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)Syon Capital LLC lifted its position in Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 25.5% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 18,079 shares of the biopharmaceutical coApril 24, 2025 | marketbeat.com Get Gilead Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for GILD and its competitors with MarketBeat's FREE daily newsletter. Email Address GILD Media Mentions By Week GILD Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GILD News Sentiment▼0.610.85▲Average Medical News Sentiment GILD News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GILD Articles This Week▼7229▲GILD Articles Average Week Get Gilead Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for GILD and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies AMGN News Today VRTX News Today REGN News Today ALNY News Today BIIB News Today UTHR News Today BMRN News Today INCY News Today EXEL News Today NBIX News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:GILD) was last updated on 4/30/2025 by MarketBeat.com Staff From Our PartnersTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | SponsoredM.A.G.A. is Finished – This Could be even BetterYou’ve no doubt heard Trump’s rally cry: Make America Great Again. But recently the President made a big ch...Paradigm Press | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredElon Musk’s next move from the Oval Office?No one is closer to President Trump than Tesla CEO Elon Musk. He's been dubbed Trump's "first buddy." Tr...Weiss Ratings | SponsoredChina’s next move could destroy U.S. techThe U.S. fired the first shot with 145% tariffs. Apple relies heavily on Chinese production. Tesla needs Ch...Investors Alley | SponsoredThis isn’t a trade war. It’s worse…Investigative Journalist Bombhsell: The Curse on the U.S Dollar Depleted retirement accounts? Meme coin inv...Stansberry Research | SponsoredTop performing AI play of the decade…? (The answer will shock you)You’ve seen the headlines about Nvidia. Now Tim Sykes is sounding the alarm — because what CEO Jensen Huang is...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Gilead Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Gilead Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy GILD Stock Free GILD Stock Alerts